Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Office of Clinical Policy and Programs

Office of Clinical Policy and Programs
            
                        Patient Affairs Staff
          Office of Combination Products
          Office of Orphan Products Development
          Office of Pediatric Therapeutics
          Office of Clinical Policy Home
          About FDA
          FDA Organization
          Office of the Commissioner
          Office of Clinical Policy and Programs
          Office of Combination ProductsOffice of Clinical Policy and Programs Office of Combination Products

    
Share
    Post
    Linkedin

    Email
    PrintWho We Are

The Office of Combination Products (OCP) assigns combination products to FDA’s medical product centers for review, helps coordinate timely, effective and aligned reviews of combination products and oversees the postmarket activities of combination products to help ensure their safety and quality in order to protect patients from harm.

What We Do

Serve as primary point of contact for combination product issues for FDA staff and industry.
	Develop guidance, regulations and standard operating procedures to clarify combination product regulation.
	Classify products as drugs, devices, biological products or combination products and assign an FDA center for premarket review and postmarket safety oversight.
	Ensure timely and effective review of combination products by overseeing and coordinating reviews involving more than one FDA center.
	Oversee postmarket safety to protect patients from potential health risks associated with combination products currently on the market.
	Facilitate dispute resolution regarding the timeliness of premarket review of combination products.
	Update agreements, guidance documents or practices specific to assigning combination products.
	Develop annual reports to Congress on the office’s activities and impacts.
	Provide training to FDA staff and regulated industry on combination product regulation.Contact Us

Email: combination@fda.gov
Phone: 301-796-8930
Fax: 301-847-8619

Office of Combination Products
Office of Clinical Policy and Programs
Food and Drug Administration
10903 New Hampshire Ave. WO-32, Room 5129
Silver Spring, MD 20993

Resources

Combination products
	Combination products guidance documents
	RFD process
	Combination products performance reports

                                                                                  Content current as of:
      09/27/2021Office of Clinical Policy and Programs
            
          
                        Patient Affairs Staff
          Office of Combination Products
          Office of Orphan Products Development
          Office of Pediatric Therapeutics
          Office of Clinical Policy
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop